Sarepta Therapeutics

Sarepta Therapeutics

World Rank (Aug-2026)
6508
Market Cap (Aug-2026)
1.912 Billion USD
Market Cap (Mar-08-2026)
1.754 Billion USD
World Rank (Jan-05-2024)
1,838
Market Cap (Jan-05-2024)
8.820 Billion USD
World Rank (Jul-30-2023)
1,662
Market Cap (Jul-30-2023)
10.109 Billion USD
World Rank (Jan-07-2022)
2,400
Market Cap (Jan-07-2022)
7.445 Billion USD
World Rank (Jan-01-2021)
1,313
Market Cap (Jan-01-2021)
13.454 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 623
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
SRPT
Employee Count
1,162
Employee Count as of Date
As on 2022
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,864 Million USD
Annual Operating Income in USD
-700 Million USD
Annual Net Income in USD
-713 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
3,350 Million USD
Total Liabilities in USD
2,209 Million USD
Total Equity in USD
1,141 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Biotechnology
Technology
HealthCare Products
Company Website
SAREPTA THERAPEUTICS INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Biotechnology company with headquarters is in Massachusetts, USA.

Annual Results Summary

SAREPTA THERAPEUTICS Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022933-536 (Loss)-703 (Loss)
Dec-2021701-449 (Loss)-418 (Loss)
Dec-2020540-564 (Loss)-554 (Loss)
Dec-2019380-522 (Loss)-715 (Loss)
Dec-2018301-345 (Loss)-361 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 3,128 Million USD.

Total Liabilities as on Dec-2022 was 2,743 Million USD.

Total Equity as on Dec-2022 was 384 Million USD.

Founded Year
1980
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share